HKPMDC
 All     Test   
 
Oncology
Oncology


Test Name: Endometrial Adenocarcinoma Classification Panel (POLE, MMR IHC & p53 IHC)
Compliance:LDT, FDA
Test Description:Endometrial cancer is the sixth most common cancer globally, newer risk stratification models aimed at improving treatment algorithms for patients with endometrial cancer are centred around molecular classification. Current guidelines from the National Comprehensive Cancer Network recommend universal testing for mismatch repair (MMR) or MSI status and acknowledge potential benefit to further molecular analysis of tumour protein TP53 and POLE status
Methodology:- PCR-Sanger sequencing analysis of mutations in POLE gene
-Immunohistochemistry
Gene Name:

POLE
Protein Name:
Specimen Requirements:FFPE tissue slides (4µm)
Storage Condition:Ambient Temperature
Turn Around Time:10 working days from day of specimen received
OMIM:
Genetic Home Reference:
Phone: +852.2986.1213
Fax:+852.2527.7028
E-mail:contact@hk-mpdc.com
27/F., Strand 50, No.50 Bonham Strand, Sheung Wan, Hong Kong
Opening Hours
Mondays to Fridays: 09:00-18:00
Saturdays: 09:00-16:00
Sundays and Public Holidays: Closed

For specimen pickup arrangements, please phone +852.2986.1213


Shipping & Billing Information

HOKLAS accreditation scope

Non-disclosure and Complaints
All data/information generated from within/related to HKMPDC and our customers are treated in strict confidence in accordance with the Personal Data (Privacy) Ordinance of Hong Kong. If you have a complaint, please contact us at the (852) 2986 1213 or email us at contact@hk-mpdc.com. All communications with HKMPDC would be dealt with in strict confidence.

Notice of Privacy Practices
This notice describes how medical information about you may be used and disclosed.
Personal health information or related information released to HKMPDC relating to the services requested may be subjected to re-disclosure by HKMPDC to health care providers, such as doctors, nurses, and others involved in the delivery of the services.
We may also disclose medical information about you to authorised public health or government officials for public health activities as required by law and accreditation body.

Copyright © 2013 香港分子病理檢驗中心 Hong Kong Molecular Pathology Diagnostic Centre Limited (HKMPDC). All Rights Reserved.

Information Updated 1 July, 2023.